健康人使用瑞舒伐他汀能够降低心脏疾病的风险。
The lowest Numbers (2%) of patients reporting myalgia were in the rosuvastatin 40-mg and simvastatin 40-mg groups.最低的数字(2%报告肌痛病人)在罗伐他汀40毫克和辛伐他汀40毫克组。
Patients can well tolerate the conventional dose of rosuvastatin, and can have serious liver or muscle damage with such dose.常规剂量应用瑞舒伐他汀患者耐受好,不会引起严重的肝脏或肌肉损害。